Skip to content

Neuropace, Inc. NPCE Interest Expense

Interest Expense at other companies

Medtronic logo
MedtronicMDT
$176M+1.1%
LivaNova logo
LivaNovaLIVN
$8.29M-45.8%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$1.38M
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$8.06M+1.9%
ITG
Integer HoldingsITGR
$9.73M-34.3%
Stryker logo
StrykerSYK
$148M+8.0%

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s interest expense?
Neuropace, Inc. (NPCE) reported interest expense of $1.52M in Q1 2026.
How has Neuropace, Inc.'s interest expense changed year-over-year?
Neuropace, Inc.'s interest expense decreased by 29.4% year-over-year, from $2.15M to $1.52M.
What is the long-term trend for Neuropace, Inc.'s interest expense?
Over 4 years (2021 to 2025), Neuropace, Inc.'s interest expense has grown at a 0.2% compound annual growth rate (CAGR), from $7.41M to $7.46M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.